SK Life Science to Unveil Groundbreaking Epilepsy Research at AAN 2026 At the AAN 2026 Annual Meeting, SK Life Science will present crucial research on cenobamate and insights from epilepsy patient-provider surveys, enhancing understanding of treatment communications.

SK Life Science to Unveil Groundbreaking Epilepsy Research at AAN 2026 #United_States #Chicago #Cenobamate #SK_Life_Science #Epilepsy

SK Life Science to Unveil Groundbreaking Cenobamate Data at 2025 AES Meeting SK Life Science will present ten impactful posters, featuring new data on cenobamate, at the 2025 AES Annual Meeting. Discover groundbreaking findings.

SK Life Science to Unveil Groundbreaking Cenobamate Data at 2025 AES Meeting #United_States #Atlanta #Cenobamate #SK_Life_Science #AES_Meeting

SK Life Science Publishes New Research on Cenobamate for Focal Seizures in Asia SK Life Science has released newly published studies analyzing the effectiveness of cenobamate for adult Asian patients with uncontrolled focal seizures, marking significant advances in CNS treatments.

SK Life Science Publishes New Research on Cenobamate for Focal Seizures in Asia #None #Cenobamate #SK_Life_Science #Paramus #Epilepsy

New Survey from SK Life Science Highlights Communication Gaps in Epilepsy Care and Its Consequences A recent survey reveals significant communication gaps between patients and healthcare providers regarding epilepsy treatment, stressing the need for better dialogue.

New Survey from SK Life Science Highlights Communication Gaps in Epilepsy Care and Its Consequences #United_States #SK_Life_Science #Paramus #Epilepsy #Seizure_Management

Exploring Advanced Epilepsy Treatments at the 2025 AES Annual Meeting Symposium Join SK Life Science at the 2025 AES Annual Meeting for an enlightening symposium discussing innovative approaches in epilepsy treatment and third-generation ASMs.

Exploring Advanced Epilepsy Treatments at the 2025 AES Annual Meeting Symposium #United_States #Atlanta #SK_Life_Science #Epilepsy #AES_Meeting

SK Life Science Unveils Powerful New Campaign for XCOPRI, Redefining Epilepsy Treatment in America This innovative campaign by SK Life Science aims to change perceptions of epilepsy treatment. It emphasizes patient empowerment, addressing fears and promoting informed discussions between patients and their doctors.

SK Life Science Unveils Powerful New Campaign for XCOPRI, Redefining Epilepsy Treatment in America #USA #SK_Life_Science #Paramus #Epilepsy #XCOPRI

SK Life Science to Present Groundbreaking XCOPRI Data at AAN 2025 Annual Meeting At the 2025 AAN Annual Meeting, SK Life Science will present pivotal research on XCOPRI, highlighting its efficacy in epilepsy management, with real-world insights.

SK Life Science to Present Groundbreaking XCOPRI Data at AAN 2025 Annual Meeting #United_States #San_Diego #Cenobamate #SK_Life_Science #XCOPRI

New Epilepsia Supplement Reveals Advances in Antiseizure Medications for Epilepsy Patients The latest Epilepsia supplement showcases the potential of third-generation antiseizure medications in achieving seizure freedom for patients with epilepsy, particularly those resistant to treatment.

New Epilepsia Supplement Reveals Advances in Antiseizure Medications for Epilepsy Patients #United_States #SK_Life_Science #Paramus #XCOPRI #Epilepsia

Dr. Sunita Misra Named Fellow of the American Epilepsy Society for Outstanding Contributions to Epilepsy Care Dr. Sunita Misra, VP at SK Life Science, has been honored as a Fellow of the American Epilepsy Society for her dedication and contributions to epilepsy research and treatment.

Dr. Sunita Misra Named Fellow of the American Epilepsy Society for Outstanding Contributions to Epilepsy Care #United_States #SK_Life_Science #Epilepsy_Society #Paramus #Dr._Sunita_Misra

SK Life Science Showcases Innovative Cenobamate Research at 2024 AES Annual Meeting in Los Angeles SK Life Science is set to present new findings on cenobamate, an anti-seizure medication, at the American Epilepsy Society's Annual Meeting 2024, addressing critical patient treatment needs.

SK Life Science Showcases Innovative Cenobamate Research at 2024 AES Annual Meeting in Los Angeles #United_States #Los_Angeles #Cenobamate #SK_Life_Science #Epilepsy_Society